Abstract:Antiangiogenesis therapy has become a hot field in cancer research. Blood vessels of tumor carry specific markers that are usually related to angiogenesis. Study of these heterogeneous molecules in different tumor vessels may be beneficial for promoting antiangiogenic therapy. In this study, we established an in vitro co-culture model of human umbilical vein endothelial cells (HUVECs) and gastric adenocarcinoma cell line SGC7901, screened the peptides binding specifically to the HUVECs co-cultured with gastric cancer cells (Co-HUVECs) using phage display peptides library, and studied the affinity of these peptides to gastric cancer vascular endothelial cells. After four rounds of panning, there was an obvious enrichment for the phages specifically binding to the Co-HUVECs, and the output/input ratio of Co-HUVECs increased about 590-fold (from 0.95×10−7 to 561.25×10−7). Five phage clones (M6, M3, M9, IN12, IN11), which could strongly bind to Co-HUVECs instead of wild-type HUVECs, were characterized by ELISA. In vitro cellular binding assay showed that phage IN11 preferably bound to Co-HUVECs rather than control HUVECs, and the number of the phage IN11 recovered from Co-HUVECs was 5.7- and 16.9-folds, respectively, as much as those from control HUVECs and GES cells. Immunocytochemical and immunohistochemical staining confirmed that phage IN11 could specifically bind to Co-HUVECs as well as vascular endothelial cells in gastric cancer tissue sections. Competitive and inhibitory assay revealed the synthetic peptide GEBP11 (CTKNSYLMC) displayed on phage IN11 could competitively inhibit binding of the phage IN11 to Co-HUVECs. Immunofluorescence microscopy showed that the fluorescence-labeled peptide GEBP11 was located at the membrane and perinuclear cytoplasm of Co-HUVECs. Meanwhile, GEBP11 was found to be able to target the gastric cancer vascular endothelial cells. Therefore, GEBP11 may be a potential candidate for targeted drug delivery in antivascular therapy and diagnosis of gastric cancer.

[Screening of Bioactive Peptide That Mimic the Epitope of Gastric Cancer Associated Antigen].

[Mimic Epitope Recognized by Monoclonal Antibody MG7 Against Gastric Cancer Through Screening Phage Displayed Random Peptide Library].

Selection and Characterization of a Peptide Specifically Targeting to Gastric Cancer Cell Line SGC-7901 Using Phage Display

Screening and Identification of Vascular-Endothelial-cell-specific Binding Peptide in Gastric Cancer

Screening and identification of a CD44v6 specific peptide using improved phage display for gastric cancer targeting

The further characterization of the peptide specifically binding to gastric cancer

Peptide Mimics of A Carbohydrate-Associated Epitope Expressed by Cancer Cells: Identification of Vaccine Candidates

Screening and identification of CD44v9 specific peptide ligand for gastric cancer detection

Characterization of a specific phage-displayed Peptide binding to vasculature of human gastric cancer.

Screening and Characterization of Inhibiting Peptides Binding to the Tumor Vascular Growth Factor Receptor

[Screening of Breast Cancer Antigen from a Phage Display Random Peptide Library].

Identifying Peptides That Specifically Bind to MDA-MB-468 Breast Cancer Cells*

Screening of a specific peptide binding to esophageal squamous carcinoma cells from phage displayed peptide library.

Monoclonal Antibodies Against Human Gastric Cancer

Selection of a Specific Binding Peptide Targeting to Blood Vessel of Human Gastric Cancer in Vivo and Modeling of Its Three Dimensional Structure

A CD44 specific peptide developed by phage display for targeting gastric cancer

Clinical Significance of Novel Identified High‐frequency Tumor‐specific Peptides Associated Signature in Predicting Disease Status of Gastric Cancer Patients

Identification of a peptide binding to cancer antigen Kita‐kyushu lung cancer antigen 1 from a phage‐display library

[Production of phage-displayed single chain variable fragments of monoclonal antibody MGb1].

Development and validation of cyclic peptide probe for gastric cancer based on phage display technique

A novel peptide isolated from a phage display peptide library with trastuzumab can mimic antigen epitope of HER-2.